|
|
Article: Geron Corporation Reports 2009 Third Quarter Financial Results and Events.(Financial report)
- Article from:
- Cancer Vaccine Week
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Geron Corporation (Nasdaq:GERN) reported financial results for the three and nine months ended September 30, 2009 (see also Geron Corporation).
For the third quarter of 2009, the company reported net loss applicable to common stockholders of $15.2 million, or $(0.17) per share, compared to $17.2 million, or $(0.22) per share, for the comparable 2008 period. Net loss applicable to common stockholders for the first nine months of 2009 was $52.0 million, or $(0.59) per share, compared to $44.4 million, or $(0.57) per share, for the comparable 2008 period.
Revenues for the third quarter of 2009 were $494,000, compared to $367,000 for the comparable 2008 ...